Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001628280-25-022872
Filing Date
2025-05-07
Accepted
2025-05-07 07:41:26
Documents
91
Period of Report
2025-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q lnth-20250331.htm   iXBRL 10-Q 1103994
2 EX-10.1 lnth10q-033125ex101.htm EX-10.1 37431
3 EX-31.1 lnth10q-033125ex311.htm EX-31.1 11664
4 EX-31.2 lnth10q-033125ex312.htm EX-31.2 11567
5 EX-32.1 lnth10q-033125ex321.htm EX-32.1 9738
11 image_0.jpg GRAPHIC 300135
12 image_1.jpg GRAPHIC 280616
  Complete submission text file 0001628280-25-022872.txt   7697868

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT lnth-20250331.xsd EX-101.SCH 55242
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT lnth-20250331_cal.xml EX-101.CAL 81399
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT lnth-20250331_def.xml EX-101.DEF 219620
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT lnth-20250331_lab.xml EX-101.LAB 653556
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT lnth-20250331_pre.xml EX-101.PRE 448163
94 EXTRACTED XBRL INSTANCE DOCUMENT lnth-20250331_htm.xml XML 854941
Mailing Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862
Business Address 331 TREBLE COVE ROAD NORTH BILLERICA MA 01862 978 671-8001
Lantheus Holdings, Inc. (Filer) CIK: 0001521036 (see all company filings)

EIN.: 352318913 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36569 | Film No.: 25919329
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
(CF Office: 03 Life Sciences)